Fig. 2From: Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCCMean tumour dose for observed responses (mRECIST). Group comparisons showed no significant differences. CR complete response, PR partial response, SD stable disease, PD progressive disease, DC disease controlBack to article page